Joren Raymenants - Concepedia

Concepedia

Author

Joren Raymenants

KU Leuven ORCID

Also Known As

Joren Raymenants, Raymenants, Joren

42

Publications

2.7K

Citations

11

H-Index

22

Concepts

All Affiliations

KU Leuven Rega Institute for Medical Research Institut de Recherche Vaccinale Centre hospitalier universitaire d'Orléans Hôpital Européen Georges-Pompidou

JR

About

Joren Raymenants is an author at KU Leuven specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	2K
2	Immunology	5	5	2K
3	Epidemiology	2	2	133
4	Engineering	1	1	35
5	Environmental Engineering	1	1	35

Joren Raymenants

×

12

Publications

2.7K

Citations

11

H-Index

	Year	Citations
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization Delphine Planas, Nell Saunders, Piet Maes, Nature Vaccine TargetImmunologyAntibody ScreeningAntibody EngineeringImmunotherapy	2021	1.6K
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern Laura Vangeel, Winston Chiu, Steven De Jonghe, Antiviral Research	2022	424
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization Delphine Planas, Nell Saunders, Piet Maes, Nature Vaccine TargetImmunologyAntibody ScreeningAntibody EngineeringImmunotherapy	2021	213
The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters Rana Abdelnabi, Caroline S. Foo, Xin Zhang, Antiviral Research	2022	120
Considerable escape of SARS-CoV-2 variant Omicron to antibody neutralization Delphine Planas, Nell Saunders, Piet Maes, Viral DiagnosticsImmunodeficienciesImmunologyImmunodominanceCovid-19	2021	98
Indoor air surveillance and factors associated with respiratory pathogen detection in community settings in Belgium Joren Raymenants, Caspar Geenen, Lore Budts, Nature Communications	2023	57
Empirical evidence on the efficiency of backward contact tracing in COVID-19 Joren Raymenants, Caspar Geenen, Jonathan Thibaut, Nature Communications	2022	42
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern Laura Vangeel, Winston Chiu, Steven De Jonghe, Gfp SignalVitro Antiviral ActivityImmunologyAntiviral ResponseAntiviral Drug Development	2021	41
Monitoring of SARS‐CoV‐2 concentration and circulation of variants of concern in wastewater of Leuven, Belgium Annabel Rector, Mandy Bloemen, Marijn Thijssen, Journal of Medical Virology EngineeringVirus EpidemiologyViral DiagnosticsMunicipal WastewaterWastewater Treatment	2023	35
The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters Rana Abdelnabi, Caroline S. Foo, Xin Zhang, Sars-cov-2 VariantSpike ProteinViral EvolutionEmerging Infectious DiseasesAnimal Virus	2021	26

Page 1